Stock Price & Overview Analyze With AI Follow74.5K followers $40.840.54 (+1.34%)12:29 PM 01/17/25 NASDAQ |$USD |Realtime CRSP Analysis CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers Investing Groups Covering CRSP
CRISPR Therapeutics AGCRSP:NASDAQ RT Quote|Last NYSE Arca, VOL From CTA|USD After Hours:Last |01/22/25 EST 44.50+0.30(+0.68%) Volume 100,218 Close 44.20+2.69(+6.48%) Volume 5,251,804 52 week range 36.52-91.10 KEY STATS Open41.65 ...
Stay up to date with the latest CRISPR Therapeutics AG stock price movements on Seeking Alpha's interactive chart. View comprehensive price data and historical prices on CRSP here.
Skip NavigationMarkets Business Investing Tech Politics Video Investing Club PRO
The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest amount that a seller is currently willing to sell. The numbers next to the bi...
Analyst Price Target is $77.59 ▲ +83.25% Upside Potential This price target is based on 20 analysts offering 12 month price targets for CRISPR Therapeutics in the last 3 months. The average price target is $77.59, with a high forecast of $105.00 and a low forecast of $48.00. The avera...
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment Dec. 9, 2023 at 7:47 a.m. ET by Eleanor Laise Biotech and Pharma FDA Approves First Two Sickle Cell Gene Therapies, bluebird bio Shares Tumble Dec. 8, 2023 at 2:54 p.m. ET by Barron's China ...
Nkarta Therapeutics stock price target cut to $36 from $50 at Oppenheimer Nov. 10, 2022 at 8:17 a.m. ETby Tomi Kilgore Activist InvestingMiMedx Group and Inozyme Stock See Action From Activist Investors May. 6, 2022 at 5:30 p.m. ET ...
Given all these factors, it seems reasonable to assume that Casgevy could grab at least a decent share, perhaps 20% of its addressable market. At a price above $1 million, this is undoubtedly a multibillion-dollar opportunity for CRISPR Therapeutics. ...
USDNasdaq Global SelectDelayed PriceMarket Closed Earnings High Target Price 14.00 Mean Target Price 9.36 Low Target Price 4.50 Standard Deviation: 3.19 Number of Estimates 11 Date of Most Recent Estimate 11/14/24 Created with Highcharts 5.0.7Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 ...